Posted on Jan 5, 2019 2018: Articles Received: 29; Accepted: 14; Rejected: 19; Published: 12; Retracted: 0 2017: Articles Received: 43; Accepted: 25; Rejected: 17; Published: 15; Retracted: 0 2016: Articles Received: 48; Accepted: 30; Rejected: 19; Published: 20; Retract Read More
Posted on Nov 1, 2018 Cancer and Clinical Oncology (CCO) is calling for submission of papers for the Vol. 8, No. 1, May 2019 issue (Deadline: April 1, 2019). You are cordially invited to submit manuscripts to CCO. If you are interested in submitting a manuscript to CCO, please Read More
Posted on Jul 23, 2018 We have introduced the new website and publishing system since July 22, 2018. The old website is shutdown, no information updated. You will enjoy the better interface and faster access to the contents and webpages, as well as a convenient process for m Read More
- Treatment of Recurrent Glioblastoma Multiforme (rGBM) with Antineoplaston AS2-1 in Combination with Targeted Therapy
- Stanislaw R. Burzynski
- Tomasz Janicki
- Samuel Beenken
- The Changes of Expression Levels in Mir-181a and Mir-30d, and a Significant Correlation between Clinical Patient Data
- Mojtaba MohammadnejhadMohammadnejad Pahmadani
- Fatemeh Jabari
- Shima Hojabri Mahani
- Reza Mahmanzar
Journal Publishing Workflow
Please see the workflow for the article publication:
Paper Selection and Publication Process
a) Upon receipt of paper submission, the Editor sends an E-mail of confirmation to the corresponding author within 1-3 working days. If you fail to receive this confirmation, your submission/e-mail may be missed. Please contact the Editor in time for that.
b) Peer review. We use double-blind system for peer-review; both reviewers and authors’ identities remain anonymous. The paper will be peer-reviewed by three experts; two reviewers from outside and one editor from the journal typically involve in reviewing a submission. The review process may take 2-3 weeks.
c) Notification of the result of review by E-mail.
d) If the submission is accepted, the authors revise accordingly and pay the publication fee (300USD).
e) A PDF version of the article is available for download on the journal’s webpage free of charge.
f) From July 1, 2018, we will not automatically provide authors free print journals. We will provide free print copies for authors who really need them. Authors are requested to kindly fill an application form to request free print copies. Additionally, we are happy to provide the journal’s eBook in PDF format for authors, free of charge. This is the same as the printed version.
Competing Interests Statement
All authors of Cancer and Clinical Oncology are requested to disclose any actual or potential conflict of interest including any financial, professional, personal or other relationships with other people or organizations, along with the paper. Download MS-Word
The publisher and journal have a policy of “Zero Tolerance on the Plagiarism”. We check the plagiarism issue through two methods: reviewer check and plagiarism prevention tool (ithenticate.com).
All submissions will be checked by iThenticate before being sent to reviewers.
This work is licensed under a Creative Commons Attribution 4.0 License.
- Lexie GreyEditorial Assistant